The majority of HIV isolated from infected patients uses CCR5 as a coreceptor (R5-HIV). Although R5-HIV fails to replicate efficiently in human transformed T-cell lines, HIV using CXCR4 (X4-HIV) can replicate well in such cell lines. Therefore, most of screening systems using the Tcell lines detect only X4-HIV replication. Here we report a new assay to monitor the replication of R5-as well as X4-HIV. An MTT assay using CD4-, CXCR4-, and CCR5-transduced human glioma NP-2 cells (NCK45 cells) was established and then compared with the representative assays including multinuclear activation of a galactosidase indicator assay (MAGI assay). The antiviral activities of not only an adsorption inhibitor and reverse transcriptase inhibitors but also a Tat antagonist in the NCK45 cells, were comparable to those obtained from the MTT assay using MT-4 cells or the MAGI assay. However, the activity of protease inhibitors (PIs) was underestimated, even though expressions of major multidrug resistant genes involved in efflux of PIs were comparable in MT-2, NP-2, and NCK45 cells. After cultivation of more than 6 months, NCK45 cells remained susceptible to HIV infection since NCK45 cells consistently expressed CD4, CXCR4, and CCR5. On the other hand, MAGI cells lost the CD4 expression during culture. Thus, this assay system can stably detect the replication of both X4-and R5-HIV, indicating that it should be useful for the evaluation of HIV replication and drug susceptibility.
Human immunodeficiency virus (HIV) infects the host cells by targeting CD4 molecules on the cell surface and the seven transmembrane-spanning G protein-coupled coreceptors, for example, CXCR4 (X4) and CCR5 (R5), via the V3 loop of gp120 (Wu et al., 1996; Berger et al., 1999) . HIV using R5 as a coreceptor (R5-HIV) has been isolated from patients in the all stages, whereas X4-HIV is isolated from patients during the later stages of disease progression towards acquired immunodeficiency syndrome (AIDS).
Transformed T-cells expressing CXCR4 on their surface, such as MT-2, H9, and Molt4 cells, are highly susceptible to X4-HIV infection, but are less susceptible, or not susceptable at all, to R5-HIV. Therefore, a novel cell line allowing R5-HIV replication is required to evaluate drug susceptibility of R5-HIV, the major isolate in patients.
Multinuclear activation of a galactosidase indicator assay (MAGI assay; Kimpton & Emerman, 1992) and p24 enzyme-linked immunosorbent assay (ELISA) with peripheral blood mononuclear cells (PBMCs) are frequently used for the evaluation of R5-HIV replication (Schupbach et al., 2000) , although these assay systems have several problems. In the MAGI assay, susceptibility to HIV infection gradually declines in HeLa CD4/CCR5/ LTRβ-galactosidase (MAGI/CCR5) cells after extensive passages and tedious counting is required to determine infectivity. In the p24 ELISA, the sample preparation is complicated and the cost of each assay is high. Moreover, expression levels of CD4, CXCR4, and CCR5 on freshly isolated PBMCs differ over a wide range depending on cell subsets and donors (Ostrowski et al., 1998; Lee et al., 1999) , and intracellular drug metabolisms in PBMCs are generally different from donor to donor, resulting in difficulties to obtain reproducible data (Ghezzi et al., 2001) .
Recently, a novel reporter assay using CCR5-transduced Molt4 (MOCHA) cells has been reported (Miyake et al., 2003) . This assay system detects Tat expression using the activity of long terminal repeat (LTR) , which transcribes secretary alkaline phosphatase (SEAP) gene and provides a simple procedure. However, MOCHA cells express various HIV coreceptors, for example, CCR3, that may influence the infectivity or activity of coreceptor antagonists (Dejucq, 2000) . Another assay using CXCR4-and CCR5-transduced U87 cells has been established previously (Princen et al., 2004) . In this assay, tedious p24 ELISA was applied to evaluate the anti-HIV activities. Moreover, U87 cells expressed various G-proteins coupled receptors that act as coreceptors not only for HIV-1 and 2, but also simian immunodeficiency viruses .
Here we developed an assay system for monitoring not only X4-but also R5-HIV replication and drug susceptibility using an MTT method, which was found to be simple and reproducible. This system can provide a convenient and stable method to screen a wide rage of anti-HIV compounds.
Materials and methods

Reagents
An adsorption inhibitor, dextran sulphate (DS5000; molecular weight 5,000), reverse transcriptase inhibitors (RTIs), 3′-azido-2′,3′-dideoxythymidine (AZT) and 2′, 3′dideoxycytidine (ddC) were purchased from Sigma (St. Louis, MO, USA) . A Tat antagonist, Ro5-3335 (Hsu et al., 1991) , and a CXCR4 antagonist, AMD3100 (Schols et al., 1997) , were a kind gift from S Shigeta (Fukushima Medical University, Fukushima, Japan) . A CXCR4 antagonist, T-140 (Fujii & Tamamura, 2001) , and the following protease inhibitors (PIs): VX-478 and nelfinavir (Livington et al., 1995; Witvrouw et al., 2004) , were kindly provided by N Fujii (Kyoto University, Kyoto, Japan) . A CCR5 antagonist, TAK-779 (Baba et al., 1999) , was obtained from the AIDS Research and Reference Program, Division of AIDS, National Institute of Allergy and Infectious Diseases (Bethesda, MD, USA) . Mouse anti-human CXCR4 monoclonal antibody (MAb; 12G5) and mouse anti-human CCR5 MAb (2D7) were purchased from BD Biosciences Clonetech (San Jose, CA, USA). Phycoerythin cyanine-5 (PC5)-conjugated mouse anti-human CD4 was purchased from Immunotech (Marseille, France) . Fluorescein isothiocyanate (FITC)-conjugated goat antimouse IgG and isotype-matched control MAb were purchased from Jackson ImmunoResearch Laboratory (West Grove, PA, USA). 1-(4,5-Dimethylthiazol-2yl)-3,5dephenylformazan (MTT) was also purchased from Sigma. -2 and MT-4 cells were propagated and maintained in RPMI1680 medium (Sigma) supplemented with 10% heatinactivated fetal calf serum (FCS), 100 U/ml penicillin G and 50 µg/ml of streptomycin. NP-2 cells derived from a human glioma were kindly provided by H Hoshino (Gunma University, Maebashi, Japan; Kanbe et al., 1999; Soda et al., 1999) . NP-2 cells were propagated and maintained in Dulbecco's modified Eagle medium (DMEM; Sigma) supplemented with 10% heat-inactivated fetal calf serum (FCS), 100 U/ml penicillin G and 50 µg/ml of streptomycin.
Cells
MT
HeLa CD4/CCR5/LTR-β-galactosidase (MAGI/CCR5) cells were obtained from M Emerman through the AIDS Research and Reference Program and were propagated in DMEM supplemented with 10% FCS, 0.2 mg/ml G418 disulphate (Nacalai Tesque, Kyoto, Japan), 0.2 mg/ml hygromycin B (Calbiochem, La Jolla, CA, USA) and 10 µg/ml puromycin (Sigma).
PBMCs were obtained from healthy HIV-seronegative donors and stimulated for 3 days with 20 U/ml of Ltd, Osaka, Japan) and 0.5 µg/ml of phytohaemagglutinin (PHA; Sigma) as previously described (Kodama et al., 2001) .
Establishment of NCK45 cells
A lentiviral transfer vector (an HIV-1-based vector), pHR, was generously gifted by I Verma (Salk Institute, La Jolla, CA, USA) , and modified for the expression of HIV-1 receptors. A packaging plasmid (pCMV∆8/9) and an envelope-coding vector (pVSV-G) were a generous gift from H Miyoshi (RIKEN, Tsukuba, Japan) .
First,we constructed pBC-CD4/CXR4-IG and introduced the genes for CD4, the internal ribosomal entry site (IRES), CXCR4, IRES, and neomycin phosphotranspherase (G418 r ) under control of a cytomegalovirus promoter, to express HIV receptors with G418 r simultaneously (as shown in Figure 1A ). The pBC-CD4/CXCR4-IG plasmid was cotransfected with pCMV∆8/9 and pVSV-G into 293T cells using FuGENE 6 transfection reagent (Roche Diagnostics, Indianapolis, IN, USA) . After 48 h of transfection, culture supernatants were harvested and placed onto NP-2 cells. The transduced NP-2 cells were subjected to G418 selection, and designated as NCK cells. Similarly, an expression vector (pBC-CCR5-IH) encoding for the chemokine receptor, CCR5, along with hygromycin B phosphotranspherase (Hygro r ) was cotransfected with pCMV∆8/9 and pVSV-G, and the culture supernatants were added to the NCK cells as described above. The transduced NCK cells were then subjected to both G418 and hygromycin B selection, and designated as NCK45 cells. NCK45 cells were further cultured in the presence of 0.5 mg/ml of G418 and 0.2 mg/ml of hygromycin B.
Viruses
HIV-1 IIIB (T cell-tropic or X4 strain), HIV-1 Ba-L (macrophage-tropic or R5 strain), HIV-2 EHO (dualtropic), and HIV-2 ROD (X4) were propagated in NCK45 cells. The virus titres were determined using both NCK45 and MAGI/CCR5 cells. The viruses were stored at -80ºC until use.
Flow cytometric analysis
The cells were digested with trypsin and then washed with phosphate-buffered saline (PBS) containing 1% FCS. The cells (10 6 cells) were incubated with anti-CXCR4, anti-CCR5, PC5-conjugated anti-CD4, or isotypematched control monoclonal antibodies (MAbs) for 30 min on ice. These cells, except for cells incubated with anti-CD4 MAbs, were washed three times with PBS containing 1% FCS, and incubated with the secondary antibody fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG ( Jackson ImmunoResearch Laboratory) for 30 min on ice. Then, all cells were washed three times with PBS containing 1% FCS and for each sample, cells were fixed with 1% formaldehyde, and analysed on an EPICS XL flow cytometer (Beckman Coulter, Miami Lakes, FL, USA) .
HIV titration
One hundred microlitres of NCK45 cells (0.5×10 4 cells/ml) were seeded in flat-bottom 96-well microtitre plates. Serial dilutions (100 µl) in 0.5 log increments of HIV-1 IIIB or HIV-1 Ba-L were added to cells and incubated at 37˚C. After 7 days of virus infection, the infectivity and the viability of HIV-inoculated cells were examined by microscopic observation.The MTT method is described below (Figure 3 ).
MTT Assay
The MTT assay using MT-4 cells was performed as previously described (Kodama et al., 2001) . The MTT assay using NCK45 cells was also performed as previously described, but with some modifications. Briefly, 100 µl of culture medium containing an appropriate concentration of compound was added in triplicate to the wells of the flat bottom 96-well microtitre plates; serial 10-fold dilutions were directly made in the plate. The NCK45 cells (0.5×10 3 cells/well) were mixed with HIV-1 IIIB or HIV-1 Ba-L at a titre of 100× the 50% tissue culture infectious dose (100 TCID 50 ) in the presence and absence of various concentrations of the compounds in the plate.The last row of wells was used as the untreated control and 100 µl of culture medium was added to the rest of the wells. At the end of the incubation period, 20 µl of the MTT solution (7.5 mg/ml in PBS) was added to each well of the plate. The plates were then incubated at 37˚C for 3 h. After incubation, 120 µl of medium was removed from each well. To dissolve the formazan crystals, 100 µl of isopropanol containing 4% Triton X-100 and 0.4% concentrated HCl was added to each well, and thoroughly mixed. After confirming microscopically that the formazan crystals were completely dissolved, the absorbance of the wells was measured using a plate reader (Model 3550, Bio-Rad Laboratories, San Jose, CA, USA) at a wavelength of 595 nm.
The 50% cytotoxic concentration (CC 50 ) of the compound was defined as the concentration that reduced the absorbance of mock-infected cells by 50% of the control. The 50% effective concentration (EC 50 ) indicated from the viral induced cytotoxicity was defined as the concentration that protected 50% of the cells against virus-induced cytopathic effect (CPE), as previously described (Kodama et al., 1996) .
MAGI assay
As previously described, anti-HIV activities were determined by the MAGI assay (Kodama et al., 2001) . Briefly, the MAGI/CCR5 cells (10 4 cells/well) were seeded in flat bottom 96-well microtitre plates. On the following day, the cells were inoculated with HIV-1 or HIV-2 (60 MAGI U/well, producing 60 blue cells after 48 h of incubation) and cultured in the presence of various concentrations of drugs in fresh medium. Forty-eight hours after viral exposure, all the blue cells stained with 5-bromo-4-chloro-3-indolyl-β-Dgalactopyranoside (X-gal) in each well were counted.
Reverse transcription (RT)-PCR
Total RNA was extracted from NP-2, NCK45, and MT-2 cells (10 5 cells) using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) . Complimentary DNA was synthesized from 1 µg of total RNA and then subjected to PCR using the RNA LA PCR Kit Ver.1.1 (TaKaRa Bio Inc, Shiga, Japan) following the manufacturer's protocol. The primer sequences used for amplification of multidrug resistance (MDR) and the related genes are listed in Table 2 .
Results
Establishment of NCK45 cells
NP-2 cells simultaneously transduced with two recombinant lentiviruses expressing CD4, CXCR4, and CCR5 were designated as NCK45 cells. We first confirmed the expression of these molecules on their surface with flow cytometric analysis. NCK45 cells were found to express CD4, CXC4R, and CCR5 as shown in Figure 1B . After infection with HIV-1 IIIB or HIV-1 Ba-L , a massive CPE was observed ( Figure 1C) , indicating that these cells were highly susceptible to both X4-and R5-HIV-1 infection. NCK45 cells are also susceptible to HIV-2 EHO and HIV-2 ROD (data not shown). Since NCK45 cells allowed efficient replication of various HIV strains used in this study, NCK45 cells were used for viral preparation.
We compared susceptibility to HIV-1 infection using long-cultured NCK45 cells with MAGI/CCR5 cells using aliquots of HIV-1 virus stock from the same lot (Figure 2) . Even after serial passage for 6 months, the infectivity to NCK45 cells remained high (85%), whereas the infectivity to MAGI/CCR5 cells severely decreased (17%). Flow cytometric analysis also revealed that the expression of these receptors was constant on NCK45 cells (data not shown). For long-term culture, expression of CD4 gradually declined on MAGI/CCR5 cells, whereas those of CXCR4 and CCR5 did not. These results indicated that simultaneous expression of HIV receptors and the selection markers, G418 r and Hygro r by inserted IRES fragments, prevented gene silencing, ensuring the continuous expression of HIV receptors.
Optimization of the MTT method
To evaluate the activity of anti-HIV agents using NCK45 cells, we determined the appropriate conditions for the MTT assay in the flowchart as shown in Figure 3E . In this optimization, we decided that the optimal optical density (OD) values were close to 1.0, given that Pauwels et al. (1988) reported that OD values of formazan resulting from conversion of MTT must be over 0.4 to obtain reproducible data. As shown in Figure 3A , the optimal cell numbers are 0.5 or 1×10 4 cells/ml, since greater cell numbers resulted in an overgrowth of the cells. Next, we K Kajiwara et al.
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Relative infectivity 0 0.5 1 Susceptibility to HIV infection (HIV-1 IIIB ) at 0 months was used as a control (gray bar). The relative susceptibility after 6 months is shown by the black bar.
Figure 2. Comparison of infectivity in NCK45 and MAGI/CCR5 cells after long-term culture
determined optimal concentrations of FCS. In the low FCS concentrations (<7.5%), OD values were unstable and low ( Figure 3B ). Cultivation over 7 days resulted in sufficient OD values ( Figure 3C ). Finally, the MTT reaction time was determined. The OD values reached 1.0 and increased little more after 3 h ( Figure 3D ), whereas the background increased after 6 h (data not shown). Thus, the optimal conditions were established to be: cell number= 0.5×10 4 cells/ml, FCS concentration=10%, culture period= 7 days and MTT reaction time= 3 h, as shown in Figure 3E .
Anti-HIV activity in NCK45 cells
The activity of various anti-HIV agents was examined in NCK45 cells. We tested various types of anti-HIV drugs: an adsorption inhibitor (DS5000), RTIs (AZT and ddC), PIs (VX-478 and nelfinavir), a Tat antagonist (Ro5-3335), CXCR4 antagonists (T-140 and AMD3100) and a CCR5 antagonist (TAK-779; Table 1 ). The activities of DS5000, AZT, ddC, and AMD3100 were similar when MT-4/MTT, MAGI, and NCK45/MTT were used for assays, whereas the activities of T-140 and the PIs were different among the assays. The activity of T-140 was 0.5, 6.0, and 29 nM for MT-4/MTT, MAGI, and NCK45/MTT, respectively. To address the incompatibility, the influence of CXCR4 expression levels on the cell's surface was examined with the flow cytometer. Results showed that MT-4 cells expressed high level of CXCR4, whereas MAGI and NCK45 cells moderately expressed it (data not shown). These results indicate that expression levels were not correlated with activity in our assay. Interestingly, Ghezzi et al. (2001) also reported similar results. Moreover, another CXCR4 antagonist, AMD3100, showed comparable activity in these assays. These results indicate that some properties of T-140, for example, stability of a peptide-based relatively large molecule, rather than those of NCK45 cells are associated with the differential activity. Since the activity of PIs was underestimated in NCK45 cells even under multi-round infection of HIV (VX-478=4.1 nM and 522 nM; nelfinavir=29 nM and >1,000 nM, in respectively) , further experiments were performed as described below.
Expression of a MDR gene in NCK45 cells
To clarify why the activities of the PIs (VX-478 and nelfinavir) were underestimated in NCK45 cells, we analysed the gene expression of major multidrug-resistant phosphoglycoproteins (MDR-p-gps) 2.5x10 3 2.5x10 4 5x10 4 10x10 4 B D E pumps that prevent the accumulation of drugs in cells. In previous reports, the expression of MDR-p-gps in the blood brain barrier has been shown to prevent the entry of PIs into the central nervous system (Cordon-Cardo et al., 1989; Kim et al., 1998; Lee et al., 1998; Edwards et al., 2005) . It is likely that NP-2 cells express MDR-p-gps, since NP-2 cells are derived from a glioma. We performed RT-PCR to examine the expression of MDRs, multidrug resistance-associated proteins (MRPs), and a breast cancer resistant protein (BCRP) gene in NP-2, NCK45, and MT-2 cells. In MT-2 cells, PIs were well evaluated in Yoshimura et al., (1999) . MT-2 cells expressed all MDR-p-gps except for MDR-3, MRP-3, and MRP-6, whereas NP-2 and NCK45 cells expressed all MDR-p-gps except for MDR-3, MRP-2, MRP-3 and MRP-6 ( Table 2) . We further examined the possibility of MDR induction with G418 and hygromycin selection; however, there were no differences in gene expression between NP-2 and NCK45 cells (data not shown). These results suggested that the major MDR-p-gps tested were not involved in the loss of PI activity.
Discussion
In this study, we established a new cell line, NCK45, to monitor the replication and their drug susceptibilities of both X4-and R5-HIV. NCK45 cells simultaneously expressed CD4, CXCR4, and CCR5 on their cell surface and allowed the use of the MTT method. The MAGI assay and p24 ELISA are frequently used as representative assays; however, these have some disadvantages. Since the MAGI assay uses the detection of intracellular Tat expression by LTR-driven β-galactosidase, it cannot evaluate drug activities that inhibit the later replication steps, for example, protease cleavage or assembly. Moreover, after prolonged passages, the levels of HIV receptors expression decreased, which resulted in reduced HIV infectivity. To stably express HIV receptors, the receptors and a drug resistant marker were simultaneously expressed by IRES. The HIV based vector may also prevent gene silencing, since it is preferentially integrated into actively transcribed genes and local hot spots of the host genome (Schroder et al., 2002) . Although gene silencing status was not analysed, NCK45 cells may escape from gene silencing. The p24 ELISA using PBMCs is useful to monitor the replication of various HIV strains. However, expression levels of HIV receptors and intracellular drug metabolisms vary between individuals, indicating that it is difficult to obtain reproducible data. Moreover, PBMCs must be stimulated with IL-2 and PHA for 3 days. We first tried to establish an MTT assay using PM-1/CCR5 or CEM/CCR5 cells. However, after HIV infection, these cells displayed persistent infections within 2 weeks of culture (data not shown).
Considering that PBMCs and MOCHA cells express various coreceptors (Dejucq et al., 1999; Dejucq, 2000) , it may be difficult to estimate the exact coreceptor antagonisms. In contrast, NP-2 cells have been shown not to express any coreceptors for HIV Soda et al., 1999; Liu et al., 2000; Shimizu et al., 2000) , suggesting that data obtained from NCK45 cells showed accurate coreceptor antagonisms. Indeed, coreceptor dependency of clinical isolates were easily evaluated in NP-2 derived cells , indicating that NCK45 cells expressing other coreceptors may enable the evaluation of various coreceptor antagonisms or agonisms.
In human T-cell leukaemia virus-I (HTLV-I) transformed cells, for example, MT-4 cells, no antiviral activities of Tat antagonist were observed even at subtoxic concentrations. It is believed that, since HIV transcription in MT-4 cells is highly activated by Tax, which is a transactivator of HTLV-I, inhibitory effect of Tat antagonist is compensated by a Tax-mediated transcriptional pathway (Witvrouw et al., 1992) . One of the obstacles appears to be the ability to perform a high throughput screening for anti-HIV transcriptional inhibitors including Tat antagonists. Taken together, the MTT assay using NCK45 cells seems to be useful especially for monitoring antagonisms of coreceptors and Tat. However, the culture periods with NCK45 cells for assays are relatively long (7 days) to obtain efficient OD value. In this respect, we plan to introduce the reporter gene (for example, β-galactosidase) to allow for a more rapid evaluation. At present, the mechanism for the reduction of PI activity in NCK45 cells remains unknown. MDR genes contribute to various drug efflux not only for PIs, but also nucleoside/nucleotide RTIs (Chow et al., 1993; Schuetz et al., 1999; Villalba et al., 1999) . However, the effects of RTIs were well evaluated in NCK45 cells. It is possible that unknown influx or efflux systems for PIs, polymorphisms or mutations in the MDR genes, and/or some altered processing of MDR gene product(s), influence the PI activities (Chaillou et al., 2002; Zhu et al., 2004) .
In conclusion, we have established a novel MTT assay for the screening of anti-R5-and X4-HIV activity using NCK45 cells. This simple and inexpensive assay should be useful for both a clinical phenotype assay and high-throughput screening of anti-HIV compounds. *Genbank accession number. † Position of primer sequence. ‡ Comparison of MDR gene expression intensity in MT-2 and NCK45 cells confirmed by RT-PCR. ++, gene expression more than control (GAPDH). ±, gene expression equal with control; -, gene expression less than control or not detected.
